Skip to content

Epidural Stimulation in Chronic Spinal Cord Injury Patients

Monitoring the Effect of Epidural Stimulation on Sensorimotor and Autonomic Functions in Chronic Patients With Spinal Cord Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05690074
Enrollment
5
Registered
2023-01-19
Start date
2023-01-01
Completion date
2025-12-30
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

spinal cord injury, spinal cord stimulation, volitional movement, functional magnetic resonance imaging, autonomic nervous system

Brief summary

Investigators propose to demonstrate that epidural stimulation (ES) can be used to recover significant levels of autonomic control of cardiovascular, urinary and sexual function as well as the ability to voluntarily control leg movements below the injury level. This intervention would provide an immediate therapeutic alternative to individuals who now have no recourse for treatment. In addition investigators suggest to prove on functional magnetic resonance imaging if there are some significant changes before and after the stimulation.

Interventions

DEVICESpectra Wave Writer™ Spinal Cord Stimulator System

Device: 5-6-5 Specify electrode Device: Restore Advance Pulse Generator

Sponsors

University Hospital, Motol
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* non-progressive SCI with complete motor paralysis below T1; American Spinal Injury Association Impairment Scale (AIS) A or B * 18 - 60 years of age; * longer than 2 years post injury; * stable medical condition * unable to voluntarily move all single joints of the legs; * spinal cort lesion between C7 and Th10

Exclusion criteria

* ventilator dependent; * painful musculoskeletal dysfunction, unhealed fracture, contracture, or pressure sore that might interfere with training; * clinically significant depression or ongoing drug abuse; * cardiovascular, respiratory, bladder, or renal disease unrelated to SCI; * severe anemia (Hgb\<8 g/dl) or hypovolemia; and HIV or AIDS related illness.

Design outcomes

Primary

MeasureTime frameDescription
Brain functional connectivity1 year after implantationResearchers want to describe if there are some changes on functional MRI of the spinal cord and brain before and after stimulation. With functional MRI in rest and task condition, the functional connectivity (FC) is examined.
Change from baseline of lower extremity independence time during after 1 year of stimulation1 year after stimulation (360 training sessions)Researchers will measure the amount of time individuals are able to stand without manual assistance (independently).

Secondary

MeasureTime frameDescription
Sexual function as measured by the Sexual Function Questionnaire3 month, 6 month, 9 month, 12 monthThe Sexual Function Questionnaire (SFQ) is a self-report outcome measure of sexual function.
Change in sense of wellbeing as measured by the World Health Organization Quality of Life (WHOQOL-BREF) questionnaire3 month, 6 month, 9 month, 12 monthThe WHOQOL-BREF assesses quality of life (QOL) within the context of an individual's culture, value systems, personal goals, standards and concerns. The higher score in the questionnaire means better quality of life for patient.
Symptoms of spasticity will be measured by Modified Ashworth spasticity test3 month, 6 month, 9 month, 12 monthThe modified Ashworth scale is the most universally accepted clinical tool used to measure the increase of muscle tone.
Change in trunk stability restoration6 month and 1 year after implantationTrunk control stability test in individuals with spinal cord injury (SCI)
Reduction of neuropathic pain3 month, 6 month, 9 month, 12 monthWe will measure neuropathic pain by the Neuropathic Pain Questionnaire (NPQ)
Change in BP during the head up tilt test (HUTT)6 month -1 yearDuring HUTT, participants will be passively moved to approximately 60° upright stand position by the investigators using the tilt table. Using epidural spinal cord stimulation (eSCS) to activate spinal sympathetic circuitry and mitigate low resting BP and orthostatic hypotension (OH) and continuous beat-by beat BP monitoring via finger photoplethysmography.
Neurogenic bowel symptoms will be measured using the Neurogenic Bowel Dysfunction (NBD) score.3 month, 6 month, 9 month, 12 monthAssessment of neurogenic bowel symptoms will be performed to assess the impact of long term eSCS on this measure. Scores can range from 0-47, with a higher score representing more severe dysfunction.
Neurogenic bladder symptoms will be measured using the Neurogenic Bladder Symptom Score (NBSS).3 month, 6 month, 9 month, 12 monthAssessment of neurogenic bladder symptoms will be performed to assess the impact of long term eSCS on this measure. The score measures bladder symptoms across 3 different domains: incontinence (scored 0-29), storage and voiding (scored 0-22), and consequences (scored 0-23), with higher scores representing worse symptoms.

Countries

Czechia

Contacts

Primary ContactVojtech Rybka, Dr.
vojtech.rybka@fnmotol.cz+420224439253

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026